Clinical Research Directory
Browse clinical research sites, groups, and studies.
McNeel Eye Center Corneal Crosslinking Study
Sponsor: McNeel Eye Center
Summary
This study will investigate the effectiveness in treating keratoconus, pellucid marginal degeneration and post LASIK iatrogenic ectasia utilizing fluence rates and treatment times of Corneal Cross Linking other than the original FDA approved protocol of 3mw/cm2.
Official title: Study of Effectiveness and Safety of Transepithelial Collagen Cross-linking at Varying Fluence Levels.
Key Details
Gender
All
Age Range
15 Years - 50 Years
Study Type
INTERVENTIONAL
Enrollment
100
Start Date
2016-09-01
Completion Date
2025-12-31
Last Updated
2025-04-06
Healthy Volunteers
Yes
Conditions
Interventions
Crosslinking using UV light of two different fluence rates
The treatment of keratoconus involves the application of riboflavin followed by Ultraviolet light of differing intensities. This study will determine the effectiveness of a greater UV light fluence at a shorter treatment time than is currently utilized.
Locations (1)
McNeel Eye Center
Boise, Idaho, United States